Gemcitabine AqVida 200 mg/vial (IV Infusion)
200 mg vial: ৳ 2,196.00
Medicine Details
Category | Details |
---|---|
Generic | Gemcitabine |
Company | Aqvida gmbh |
Also available as |
Title
- Gemcitabine AqVida AqVida
Categories
- Medicine
- Chemotherapy
- Cancer Treatment
- Pharmaceuticals
Indications
- Treatment of Non-Small Cell Lung Cancer
- Treatment of Pancreatic Cancer
- Treatment of Bladder Cancer
- Treatment of Breast Cancer
- Treatment of Ovarian Cancer
DosageAndAdministration
- Recommended dose for Non-Small Cell Lung Cancer
- Recommended dose for Pancreatic Cancer
- Recommended dose for Bladder Cancer
- Recommended dose for Breast Cancer
- Recommended dose for Ovarian Cancer
Pharmacology
- Metabolized intracellularly by nucleoside kinases
- Cytotoxic action due to inhibition of DNA synthesis
- Competes with dCTP for incorporation into DNA
- Induces programmed cellular death process (apoptosis)
Interaction
- No confirmed drug interactions reported
Contraindications
- Known hypersensitivity to Gemcitabine or its components
SideEffects
- Haematological toxicity
- Hepatic toxicity
- Gastrointestinal effects
- Genito-urinary toxicity
- Pulmonary toxicity
- Allergic reactions
- Neurotoxicity
- Alopecia
PregnancyAndLactation
- Pregnancy Category D
- Use during pregnancy
- Unknown excretion in human breast milk
PrecautionsAndWarnings
- Caution in patients with risk of toxicity
- Caution in patients undergoing radiation therapy
- Caution in patients with impairment of fertility
UseInSpecialPopulations
- Elderly patients
- Renal and hepatic impairment
- Limited data in children
OverdoseEffects
- No known antidote for overdoses
- Monitor with appropriate blood counts
- Supportive therapy
TherapeuticClass
- Cytotoxic Chemotherapy
StorageConditions
- Store at 20°C to 25°C
- Away from light
- Do not refrigerate
Related Brands
- Gemcitabin Hexal 200 mg/vial (IV Infusion) - sandoz-a-novartis-division
- Gemcetin 200 mg/vial (IV Infusion) - techno-drugs-ltd
- Gemcitabine PhaRes 200 mg/vial (IV Infusion) - thymoorgan-pharmazie-gmbh-germany
- Gitabin 200 mg/vial (IV Infusion) - bots-pvt-limited
- Gemoxen 200 mg/vial (IV Infusion) - beacon-pharmaceuticals-plc